Booth

3137

28-03-2026 to 30-03-2026

New Orleans

Concept Medical at ACC 2026

At ACC 2026, Concept Medical reinforced its leadership in drug-coated balloon innovation by presenting its next-generation Sirolimus Drug-Coated Balloon (DCB) platform for the treatment of coronary and peripheral artery disease.

The Future of Drug-Coated Balloon Therapy

Our next-generation drug-coated balloon technologies are redefining minimally invasive coronary and peripheral vascular care driven by innovation, strong clinical data, and a commitment to better patient outcomes.

Nanolute - Sirolimus Coated Balloon- MagicTouch

Location

New Orleans

Dates

28-03-2026 to 30-03-2026

Booth

3137

Find us faster with our booth locator map and save your slot with our USA team.

Late-Breaking Clinical Trials VII

Expert‑led session exploring cutting‑edge research and innovative approaches to cardiovascular care.

Primary Efficacy and Safety Results From the Phase 3 Sirolimus-Coated Balloon For Infra-inguinal Peripheral Arterial Disease (SirPAD) Trial

Book a meeting

Meet the Concept Medical team at ACC 2026 and discover the science, innovation, and clinical insights driving our advanced drug-coated balloon technology.











    Contact

    For press/clinical inquiries, include your institution and area of interest for the fastest routing.
    By submitting the form, you agree to receive relevant updates from Concept Medical. You can unsubscribe anytime.